GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mountain Valley MD Holdings Inc (FRA:20MP) » Definitions » Research & Development

Mountain Valley MD Holdings (FRA:20MP) Research & Development : €0.43 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Mountain Valley MD Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Mountain Valley MD Holdings's Research & Development for the three months ended in Dec. 2023 was €0.08 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €0.43 Mil.


Mountain Valley MD Holdings Research & Development Historical Data

The historical data trend for Mountain Valley MD Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mountain Valley MD Holdings Research & Development Chart

Mountain Valley MD Holdings Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Research & Development
0.03 0.91 1.58 1.00

Mountain Valley MD Holdings Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.19 0.34 - 0.08

Mountain Valley MD Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mountain Valley MD Holdings  (FRA:20MP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Mountain Valley MD Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Mountain Valley MD Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Mountain Valley MD Holdings (FRA:20MP) Business Description

Traded in Other Exchanges
Address
260 Edgeley Boulevard, Unit 4, Vaughan, ON, CAN, L6K 3Y4
Mountain Valley MD Holdings Inc is a Canada-based company. The firm along with its subsidiaries is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The Quicksome desiccation technology utilizes liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats that are consumed orally.

Mountain Valley MD Holdings (FRA:20MP) Headlines

No Headlines